Literature DB >> 7767323

Stimulation of CRH-mediated ACTH secretion by central administration of neurotensin: evidence for the participation of the paraventricular nucleus.

W Rowe1, V Viau, M J Meaney, R Quirion.   

Abstract

Central administration of neurotensin (NT) stimulates hypothalamic-pituitary-adrenal (HPA) activity in freely-moving rats. Increases in adrenocorticotropin hormone (ACTH) and corticosterone (B) were observed 15 min following central NT administration and remained elevated for up to 4 h. Of the two NT fragments tested, NT1-8 and NT8-13, only NT8-13 was found to significantly elevate ACTH and B levels. Moreover, NT8-13 activated the HPA axis with a temporal profile similar to NT1-13, suggesting an interaction with the pharmacologically and molecularly characterized NT receptor. Animals pre-treated intravenously with the corticotropin-releasing hormone (CRH) antagonist, alpha-helical CRH, showed attenuated plasma ACTH and B responses to central NT administration. This indicates that CRH receptor activation is necessary for the stimulatory effects of NT on HPA function. Bilateral lesions of the paraventricular nucleus (PVN) of the hypothalamus significantly reduced NT-induced stimulation of ACTH and B release suggesting that the PVN is essential for NT's stimulatory action. Median eminence content studies indicated that acute central NT administration stimulates CRH, but not arginine vassopressin (AVP), release in animals examined 60 min following NT injection. Taken together, these findings suggest that the stimulatory effects of NT on HPA activity occur via specific NT receptors and that one site of action of NT is likely at the level of the PVN where NT elicits the release of CRH.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7767323     DOI: 10.1111/j.1365-2826.1995.tb00673.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  6 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

2.  Altered gene expression in mice selected for high maternal aggression.

Authors:  S C Gammie; A P Auger; H M Jessen; R J Vanzo; T A Awad; S A Stevenson
Journal:  Genes Brain Behav       Date:  2006-08-29       Impact factor: 3.449

3.  Steroid effects on brain functions: an example of the action of glucocorticoids on central dopaminergic and neurotensinergic systems.

Authors:  W Rostène; A Sarrieau; A Nicot; V Scarceriaux; C Betancur; D Gully; M Meaney; W Rowe; R De Kloet; D Pelaprat
Journal:  J Psychiatry Neurosci       Date:  1995-11       Impact factor: 6.186

4.  Endogenous CNS expression of neurotensin and neurotensin receptors is altered during the postpartum period in outbred mice.

Authors:  Terri M Driessen; Changjiu Zhao; Anna Whittlinger; Horecia Williams; Stephen C Gammie
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

5.  Diverse roles of neurotensin agonists in the central nervous system.

Authors:  Mona Boules; Zhimin Li; Kristin Smith; Paul Fredrickson; Elliott Richelson
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-22       Impact factor: 5.555

6.  Whole-genome resequencing of Xishuangbanna fighting chicken to identify signatures of selection.

Authors:  Xing Guo; Qi Fang; Chendong Ma; Bangyuan Zhou; Yi Wan; Runshen Jiang
Journal:  Genet Sel Evol       Date:  2016-08-26       Impact factor: 4.297

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.